Nutriband Inc., led by CEO Gareth Sheridan, announced plans to scale up manufacturing of its AVERSA Fentanyl product with Kindeva and target FDA approval.

1 report, 0 independent Updated Jul 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA Gareth Sheridan

Keep exploring

Part of

Gareth Sheridan announced his presidential nomination in Ireland while serving as CEO of Nutriband Inc., whose product AVERSA Fentanyl also had an FDA meeting request. All 1 developments

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Gareth Sheridan
Irish entrepreneur and businessman

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 2Unknown outlet